| RS1666039804 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1666121550 |
OTOF
|
Health Risk |
Pathogenic |
— |
| RS1666192928 |
MTR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS1666202984 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1666206875 |
DYNC2LI1
|
Health Risk |
Likely pathogenic |
— |
| RS1666207064 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1666230230 |
PTPRC
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS1666247177 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1666264316 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1666268592 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1666291169 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1666295144 |
MTR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblG, Thymoma |
| RS1666303205 |
IFT172
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Bardet-Biedl syndrome 20 |
| RS1666304645 |
LAMB3
|
Health Risk |
Likely pathogenic |
— |
| RS1666320034 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS1666321359 |
CAMTA1
|
Health Risk |
Pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS1666408900 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1666418404 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1666422338 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1666431089 |
LAMB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa |
| RS1666432128 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1666434871 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS1666482613 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1666505168 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1666507638 |
LAMB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1666514563 |
LAMB3
|
Health Risk |
Likely pathogenic |
— |
| RS1666522276 |
CFH
|
Health Risk |
Likely pathogenic |
— |
| RS1666542456 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1666602075 |
SIX3
|
Health Risk |
Likely pathogenic |
— |
| RS1666605262 |
SIX3
|
Health Risk |
Likely pathogenic |
Holoprosencephaly 2, Holoprosencephaly 2 |
| RS1666607402 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1666615300 |
LAMB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1666616178 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1666645866 |
LAMB3
|
Health Risk |
Likely pathogenic |
— |
| RS1666646272 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1666692498 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 2, Marshall syndrome |
| RS1666728055 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1666730460 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1666730991 |
MSH2
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Hereditary cancer-predisposing syndrome |
| RS1666731161 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1666731883 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1666733944 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1666736220 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1666753666 |
LAMB3
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1A, Junctional epidermolysis bullosa |
| RS1666790331 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile liver failure syndrome 2, Infantile liver failure syndrome 2 |
| RS1666819553 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1666821581 |
KIDINS220
|
Health Risk |
Pathogenic |
Spastic paraplegia, intellectual disability |
| RS1666824711 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1666824858 |
LAMB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Amelogenesis imperfecta type 1A, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1666836481 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS1666894595 |
MSH2
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Lynch-like syndrome |
| RS1666897900 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1666899452 |
MSH2
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Lynch-like syndrome |
| RS1666901220 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1666904987 |
MSH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome |
| RS1666905944 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS1666906992 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1666944608 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1667056053 |
PPP1CB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1667056923 |
CHD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Global developmental delay, Intellectual disability |
| RS1667063572 |
SRD5A2
|
Health Risk |
Pathogenic |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| RS1667066366 |
SRD5A2
|
Health Risk |
Pathogenic |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| RS1667073440 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1667075835 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1667076297 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1667076589 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS1667077650 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1667078647 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1667109933 |
OTOF
|
Health Risk |
Likely pathogenic |
— |
| RS1667142761 |
MUC1
|
Health Risk |
Pathogenic |
Tubulointerstitial kidney disease, autosomal dominant |
| RS1667161380 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS1667163007 |
HEATR5B
|
Health Risk |
Likely pathogenic |
HEATR5B-associated Pontocerebellar hypoplasia, Congenital pontocerebellar hypoplasia |
| RS1667208458 |
COL11A1
|
Health Risk |
Likely pathogenic |
Fibrochondrogenesis 1, Marshall syndrome |
| RS1667224478 |
HEATR5B
|
Health Risk |
Likely pathogenic |
HEATR5B-associated Pontocerebellar hypoplasia, Congenital pontocerebellar hypoplasia |
| RS1667229261 |
MSH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Lynch syndrome 1, Hereditary cancer-predisposing syndrome |
| RS1667236103 |
MSH2
|
Health Risk |
Pathogenic |
— |
| RS1667236175 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome |
| RS1667240403 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1667243318 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome 1, Hereditary cancer-predisposing syndrome |
| RS1667245819 |
MSH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS1667245915 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS1667248887 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1667251882 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS1667252115 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS1667260204 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS1667260968 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS1667264651 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis |
| RS1667266283 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS1667269806 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1667270187 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS1667302018 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1667303361 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms |
| RS1667303602 |
MSH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1667305232 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1667306622 |
MSH2
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Lynch-like syndrome |
| RS1667309466 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1667311758 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1667312762 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1667313093 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS1667314337 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Usher syndrome type 2A |